Ulrich-Frank Pape P.
- Country
- Germany
- Department
- Internal Medicine and Gastroenterology
Research Overview
Data & Insights
Has run more than one trial at 0 of 12 partner sites.
Specializations
Cardiovascular Therapeutics
Focus on innovative strategies to reduce thrombo‑embolic risk and improve outcomes in patients with atrial fibrillation and heart failure phenotypes.
- atrial fibrillation anticoagulation optimization
- Management of heart failure with preserved ejection fraction and mildly reduced ejection fraction
- Prevention of stroke in cardioembolic settings
Research integrates novel oral agents with standard care to address cardiovascular morbidity.
Hepatology and Viral Hepatitis
Dedicated to advancing treatment options for chronic viral liver diseases, especially infections that lack curative therapies.
- Long‑term efficacy of therapies for chronic hepatitis D infection
- Assessment of liver disease progression in treated cohorts
- Safety profiling of novel antiviral regimens
Efforts aim to reduce liver‑related complications and improve quality of life.
Gastrointestinal and Short Bowel Management
Specializes in the care of patients with extensive intestinal loss, focusing on nutritional support and intestinal adaptation.
- Treatment of short bowel syndrome with intestinal failure
- Evaluation of agents that enhance intestinal absorption
- Safety and tolerability of long‑term therapies in intestinal failure
Clinical work emphasizes reducing dependence on parenteral nutrition.
Hematologic Malignancies
Concentrates on targeted and cellular therapies for aggressive blood cancers and related disorders.
- Novel regimens for acute myeloid leukemia and high‑risk subsets
- Combination approaches in myelodysplastic syndrome with excess blasts
- Therapeutic strategies for multiple myeloma relapse after autologous transplant
- Cellular immunotherapy for relapsed/refractory diffuse large B‑cell lymphoma
- Targeted treatment of primary mediastinal large B‑cell lymphoma
Investigations seek to improve event‑free and overall survival in high‑risk populations.
Neuroendocrine and Head‑Neck Oncology
Explores therapeutic avenues for rare solid tumours, including hormone‑active neoplasms and virus‑associated cancers.
- Management of advanced extrapulmonary neuroendocrine carcinoma
- Optimizing outcomes in HPV‑positive oropharyngeal cancer through de‑intensified protocols
- Assessment of symptom control for carcinoid syndrome
Research prioritizes efficacy while minimizing treatment‑related toxicity.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.